Axsome Therapeutics AXSM Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's prepaid & other current?
- Axsome Therapeutics (AXSM) reported prepaid & other current of $23.52M in Q1 2026.
- How has Axsome Therapeutics's prepaid & other current changed year-over-year?
- Axsome Therapeutics's prepaid & other current increased by 47.0% year-over-year, from $16.01M to $23.52M.
- What is the long-term trend for Axsome Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Axsome Therapeutics's prepaid & other current has grown at a 147.0% compound annual growth rate (CAGR), from $148.37K to $13.65M.
- What does prepaid & other current mean?
- Payments made for future services or other assets expected to be used within one year.
- How do you interpret prepaid & other current?
- Significant fluctuations may indicate changes in the scale of operations or timing of large service contracts like clinical research organizations.
- How does prepaid & other current compare across companies?
- Common across all industries; levels are generally proportional to the size of operational expenditures.